Evidence map›Paper›PMID 31013936›Full record

ReviewInternational journal of molecular sciences2019

Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.

Viola Camilla Scoffone, Gabriele Trespidi, Laurent R Chiarelli, Giulia Barbieri, Silvia Buroni

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Inhibition of biofilm formation, quorum sensing and virulence factor production in Pseudomonas aeruginosa PAO1 by selected LasR inhibitors.International microbiology : the official journal of the Spanish Society for Microbiology · 2023
    Article
  13. Article
  14. Anti-Biofilm Activity of Chlorogenic Acid againstFoods (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Review
  17. Adaptation ofMicrobiology (Reading, England) · 2023
    Article
  18. Review
  19. Attenuation ofPolymers · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Viola Camilla ScoffoneDipartimento di Biologia e Biotecnologie, Università degli Studi di Pavia, 27100 Pavia, Italy. viola.scoffone@unipv.it.
Gabriele TrespidiDipartimento di Biologia e Biotecnologie, Università degli Studi di Pavia, 27100 Pavia, Italy. gabriele.trespidi01@universitadipavia.it.
Laurent R ChiarelliDipartimento di Biologia e Biotecnologie, Università degli Studi di Pavia, 27100 Pavia, Italy. laurent.chiarelli@unipv.it.
Giulia BarbieriDipartimento di Biologia e Biotecnologie, Università degli Studi di Pavia, 27100 Pavia, Italy. giulia.barbieri@unipv.it.
Silvia BuroniDipartimento di Biologia e Biotecnologie, Università degli Studi di Pavia, 27100 Pavia, Italy. silvia.buroni@unipv.it.
University of Pavia · IT

Funding

Italian Ministry of Education, University and Research (MIUR) Dipartimenti di Eccellenza Program (2018-2022)Università degli Studi di Pavia BSR1718555
6 · The paper itself

Abstract

Cystic fibrosis (CF) is an autosomal recessive genetic disorder which leads to the secretion of a viscous mucus layer on the respiratory epithelium that facilitates colonization by various bacterial pathogens. The problem of drug resistance has been reported for all the species able to colonize the lung of CF patients, so alternative treatments are urgently needed. In this context, a valid approach is to investigate new natural and synthetic molecules for their ability to counteract alternative pathways, such as virulence regulating quorum sensing (QS). In this review we describe the pathogens most commonly associated with CF lung infections:

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaBacterial InfectionsCystic FibrosisDrug DiscoveryHumansQuorum SensingVirulenceVirulence FactorsAnti-Bacterial AgentsVirulence Factorsbacterial infectionscystic fibrosisquorum sensing

Identifiers

PMID31013936
PMCPMC6515091
OpenAlexW2936783193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.